0       0

33rd Annual North American Cystic Fibrosis Conference


S04 - S04--INF/MIC-NT: Bacteriophage Therapy for Airway Infection: What is the Potential for CF?


Oct 31, 2019 2:00pm ‐ Oct 31, 2019 3:45pm

Description

This session will explore the potential for bacteriophage therapy as an anti-bacterial therapy for airway infection in CF. The session will include three presentations that will focus on (i) the fundamentals of bacteriophage biology, (ii) a brief history of the use of bacteriophages as anti-infective therapy in humans, and (iii) potential obstacles to the use of bacteriophage therapy in CF.

Learning Objectives:

  • Review the basics of bacteriophage biology and ecology with respect to their antibacterial activity.   
  • Describe the history of bacteriophages as antibacterial therapy for human infection. 
  • Summarize the potential obstacles that challenge the use of bacteriophages for therapy of airway infection in CF.

    Symposium Chair(s):

    Symposium Speaker(s):

    You must be logged in and own this session in order to post comments.

    Print Certificate
    Review Answers
    Print Transcript
    Completed on: token-completed_on
    Review Answers
    Please select the appropriate credit type:
    /
    test_id: 
    credits: 
    completed on: 
    rendered in: 
    * - Indicates answer is required.
    token-content
    token-speaker-name image
    token-speaker-name
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    /
    /
    token-index
    token-content